Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Cantor Fitzgerald
Healthtrust
Citi
Moodys
Julphar
Deloitte
Fuji
Cerilliant
Boehringer Ingelheim

Generated: February 24, 2018

DrugPatentWatch Database Preview

Amoxapine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for amoxapine and what is the scope of amoxapine patent protection?

Amoxapine
is the generic ingredient in two branded drugs marketed by Upsher-smith Labs, Watson Labs, Watson Pharms Teva, and Lederle, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for amoxapine. Four suppliers are listed for this compound.

US Patents and Regulatory Information for amoxapine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Pharms Teva AMOXAPINE amoxapine TABLET;ORAL 072419-001 May 11, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs AMOXAPINE amoxapine TABLET;ORAL 072689-001 Aug 28, 1992 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Pharms Teva AMOXAPINE amoxapine TABLET;ORAL 072418-001 May 11, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Upsher-smith Labs AMOXAPINE amoxapine TABLET;ORAL 072944-001 Jun 28, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs AMOXAPINE amoxapine TABLET;ORAL 072691-001 Aug 28, 1992 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs AMOXAPINE amoxapine TABLET;ORAL 072690-001 Aug 28, 1992 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs AMOXAPINE amoxapine TABLET;ORAL 072688-001 Aug 28, 1992 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for amoxapine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lederle ASENDIN amoxapine TABLET;ORAL 018021-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-004 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-003 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ASENDIN amoxapine TABLET;ORAL 018021-004 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Dow
McKinsey
AstraZeneca
Mallinckrodt
Chubb
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot